199 related articles for article (PubMed ID: 12014655)
1. The effect of taurolidine on brain tumor cells.
Stendel R; Stoltenburg-Didinger G; Al Keikh CL; Wattrodt M; Brock M
Anticancer Res; 2002; 22(2A):809-14. PubMed ID: 12014655
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of Fas-ligand-mediated programmed cell death by taurolidine.
Stendel R; Scheurer L; Stoltenburg-Didinger G; Brock M; Möhler H
Anticancer Res; 2003; 23(3B):2309-14. PubMed ID: 12894508
[TBL] [Abstract][Full Text] [Related]
3. Taurolidine: cytotoxic and mechanistic evaluation of a novel antineoplastic agent.
Calabresi P; Goulette FA; Darnowski JW
Cancer Res; 2001 Sep; 61(18):6816-21. PubMed ID: 11559556
[TBL] [Abstract][Full Text] [Related]
4. Taurolidine induces apoptosis of murine melanoma cells in vitro and in vivo by modulation of the Bcl-2 family proteins.
Sun BS; Wang JH; Liu LL; Gong SL; Redmond HP
J Surg Oncol; 2007 Sep; 96(3):241-8. PubMed ID: 17469118
[TBL] [Abstract][Full Text] [Related]
5. The effects of taurolidine, a novel antineoplastic agent, on human malignant mesothelioma.
Nici L; Monfils B; Calabresi P
Clin Cancer Res; 2004 Nov; 10(22):7655-61. PubMed ID: 15569998
[TBL] [Abstract][Full Text] [Related]
6. Taurolidine improves survival by abrogating the accelerated development and proliferation of solid tumors and development of organ metastases from circulating tumor cells released following surgery.
Da Costa ML; Redmond HP; Bouchier-Hayes DJ
J Surg Res; 2001 Dec; 101(2):111-9. PubMed ID: 11735264
[TBL] [Abstract][Full Text] [Related]
7. Taurolidine-Fibrin-Sealant-Matrix using spray application for local treatment of brain tumors.
Stendel R; Scheurer L; Schlatterer K; Gminski R; Möhler H
Anticancer Res; 2004; 24(2B):631-8. PubMed ID: 15161005
[TBL] [Abstract][Full Text] [Related]
8. Treatment of glioblastoma with intravenous taurolidine. First clinical experience.
Stendel R; Picht T; Schilling A; Heidenreich J; Loddenkemper C; Jänisch W; Brock M
Anticancer Res; 2004; 24(2C):1143-7. PubMed ID: 15154639
[TBL] [Abstract][Full Text] [Related]
9. Induction of reactive oxygen intermediates-dependent programmed cell death in human malignant ex vivo glioma cells and inhibition of the vascular endothelial growth factor production by taurolidine.
Rodak R; Kubota H; Ishihara H; Eugster HP; Könü D; Möhler H; Yonekawa Y; Frei K
J Neurosurg; 2005 Jun; 102(6):1055-68. PubMed ID: 16028765
[TBL] [Abstract][Full Text] [Related]
10. Influence of intraperitoneal application of taurolidine/heparin on expression of adhesion molecules and colon cancer in rats undergoing laparoscopy.
Bobrich E; Braumann C; Opitz I; Menenakos C; Kristiansen G; Jacobi CA
J Surg Res; 2007 Jan; 137(1):75-82. PubMed ID: 17109891
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic and antineoplastic evaluation of taurolidine in the DU145 model of human prostate cancer.
Darnowski JW; Goulette FA; Cousens LP; Chatterjee D; Calabresi P
Cancer Chemother Pharmacol; 2004 Sep; 54(3):249-58. PubMed ID: 15173956
[TBL] [Abstract][Full Text] [Related]
12. Divergent effects of taurolidine as potential anti-neoplastic agent: inhibition of bladder carcinoma cells in vitro and promotion of bladder tumor in vivo.
Abramjuk C; Bueschges M; Schnorr J; Jung K; Staack A; Lein M
Oncol Rep; 2009 Aug; 22(2):409-14. PubMed ID: 19578784
[TBL] [Abstract][Full Text] [Related]
13. Taurolidine and povidone-iodine induce different types of cell death in malignant pleural mesothelioma.
Opitz I; Sigrist B; Hillinger S; Lardinois D; Stahel R; Weder W; Hopkins-Donaldson S
Lung Cancer; 2007 Jun; 56(3):327-36. PubMed ID: 17383050
[TBL] [Abstract][Full Text] [Related]
14. Taurolidine specifically inhibits growth of neuroblastoma cell lines in vitro.
Luckert C; Eschenburg G; Roth B; Appl B; Reinshagen K; Bergholz R
J Pediatr Hematol Oncol; 2014 May; 36(4):e219-23. PubMed ID: 24762556
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships of alkylphosphocholine derivatives: antineoplastic action on brain tumor cell lines in vitro.
Jendrossek V; Hammersen K; Erdlenbruch B; Kugler W; Krügener R; Eibl H; Lakomek M
Cancer Chemother Pharmacol; 2002 Jul; 50(1):71-9. PubMed ID: 12111115
[TBL] [Abstract][Full Text] [Related]
16. Taurolidine inhibits tumor cell growth in vitro and in vivo.
McCourt M; Wang JH; Sookhai S; Redmond HP
Ann Surg Oncol; 2000 Oct; 7(9):685-91. PubMed ID: 11034247
[TBL] [Abstract][Full Text] [Related]
17. Effect of As2O3 on cell cycle progression and cyclins D1 and B1 expression in two glioblastoma cell lines differing in p53 status.
Zhao S; Tsuchida T; Kawakami K; Shi C; Kawamoto K
Int J Oncol; 2002 Jul; 21(1):49-55. PubMed ID: 12063549
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effects of erucylphosphocholine on brain tumor cells in vitro and in vivo.
Erdlenbruch B; Jendrossek V; Marx M; Hunold A; Eibl H; Lakomek M
Anticancer Res; 1998; 18(4A):2551-7. PubMed ID: 9703909
[TBL] [Abstract][Full Text] [Related]
19. The excitatory amino acid transporter-2 induces apoptosis and decreases glioma growth in vitro and in vivo.
de Groot JF; Liu TJ; Fuller G; Yung WK
Cancer Res; 2005 Mar; 65(5):1934-40. PubMed ID: 15753393
[TBL] [Abstract][Full Text] [Related]
20. Differential chemosensitivity in human intracerebral gliomas measured by flow cytometric DNA analysis.
Iwadate Y; Fujimoto S; Yamaura A
Int J Mol Med; 2002 Aug; 10(2):187-92. PubMed ID: 12119557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
